Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors

Published:2021-02-25 Issue: Volume: Page:
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Cobain Erin F.¹,Wu Yi-Mi²³,Vats Pankaj²,Chugh Rashmi¹,Worden Francis¹,Smith David C.¹,Schuetze Scott M.¹,Zalupski Mark M.¹,Sahai Vaibhav¹,Alva Ajjai¹²,Schott Anne F.¹,Caram Megan E. V.¹,Hayes Daniel F.¹,Stoffel Elena M.¹,Jacobs Michelle F.¹,Kumar-Sinha Chandan²³,Cao Xuhong²,Wang Rui²,Lucas David³,Ning Yu²,Rabban Erica²,Bell Janice²,Camelo-Piragua Sandra³,Udager Aaron M.²³,Cieslik Marcin²³,Lonigro Robert J.²,Kunju Lakshmi P.²³,Robinson Dan R.²³,Talpaz Moshe¹⁴,Chinnaiyan Arul M.²³⁴⁵⁶

Affiliation:

1. Department of Internal Medicine, University of Michigan, Ann Arbor

2. Michigan Center for Translational Pathology, University of Michigan, Ann Arbor

3. Department of Pathology, University of Michigan, Ann Arbor

4. Rogel Cancer Center, University of Michigan, Ann Arbor

5. Department of Urology, University of Michigan, Ann Arbor

6. Howard Hughes Medical Institute, University of Michigan, Ann Arbor

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2776760/jamaoncology_cobain_2021_oi_200115_1613574429.81704.pdf

Reference35 articles.

1. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC.;Ramalingam;N Engl J Med,2020

2. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.;Slamon;N Engl J Med,2001

3. Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study.;Marabelle;J Clin Oncol,2020

4. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.;Flaherty;N Engl J Med,2012

5. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.;Le;Science,2017

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors for a broad technology assessment of comprehensive genomic profiling in advanced cancer, a systematic review;Critical Reviews in Oncology/Hematology;2024-10

2. Phase II trial of multi-kinase inhibitor ESK981 in patients with metastatic castration-resistant prostate cancer;Investigational New Drugs;2024-09-03

3. Sociodemographic and Clinical Characteristics Associated with Genetic Testing among Cancer Survivors: Evidence from Three Cancer Registries;Public Health Genomics;2024-08-05

4. Addressing the knowledge gap in the genomic landscape and tailored therapeutic approaches to adolescent and young adult cancers;ESMO Open;2024-08

5. Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial;Clinical Cancer Research;2024-05-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3